<DOC>
	<DOCNO>NCT00858702</DOCNO>
	<brief_summary>The purpose study test efficacy safety combination Calcium Channel Blockers ( CCBs ) ( dihydropyridine class ) Diuretics ( thiazide class ) olmesartan medoxomil essential hypertensive patient whose blood pressure adequately control olmesartan medoxomil alone</brief_summary>
	<brief_title>Calcium Channel Blockers ( CCBs ) Diuretics Add-on Olmesartan Medoxomil Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<criteria>Mean seat blood pressure great equal 140/90 mmHg circumstance pretreatment olmesartan medoxomil Mean 24hour blood pressure evaluate ambulatory blood pressure monitoring great equal 135/80 mmHg circumstance pretreatment olmesartan medoxomil Patients secondary hypertension Any serious disorder may limit ability evaluate efficacy safety test drug</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Essential hypertension</keyword>
	<keyword>Combination therapy</keyword>
</DOC>